Pocketing $4.1M in Financing, Gene-IT Plans To Roll Out Search Tools for RNAi, Diagnostics | GenomeWeb

Gene-IT plans to use $4.1 million in first-round financing to launch several new applications within three to six months for its flagship GenomeQuest sequence search product, company officials told BioInform last week.

Ronald Ranauro, CEO of Gene-IT, said that the company plans to use the funds from the Series A round — led by Cross Atlantic Partners and Milestone Venture Partners with reinvestment from Société Générale Asset Management Alternative Investments — to build out its product platform and its sales and marketing force.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.